• Structural Insights into CD38 CAR Affinity Tuning and Epitop

  2026-05-07

  This study provides a detailed structural and functional analysis of two CD38-targeting CAR binders, revealing distinct mechanisms of antigen engagement and enzymatic inhibition. The rational engineering of binder affinity demonstrates a path for optimizing CAR-T cell selectivity and minimizing fratricide, with implications for safer and more effective therapies against hematologic malignancies.

• Mianserin HCl as a 5-HT2 Antagonist: Clinical Evidence and M

  2026-05-07

  This article reviews Coppen et al.'s foundational clinical trial of Mianserin Hydrochloride, which established its efficacy as an antidepressant with a reduced side effect burden compared to amitriptyline. The study's rigorous measurement of plasma drug levels, blinded assessment, and systematic side effect tracking provide a benchmark for antidepressant research and highlight the compound's value for investigating serotonergic modulation.

• Alternariol in Mycotoxin Research: Applied Protocols & Insig

  2026-05-06

  Alternariol (AOH) is emerging as a pivotal mycotoxin research tool, enabling precise dissection of hepatotoxicity and apoptosis mechanisms. This guide translates the latest omics-driven findings and real-world troubleshooting into actionable workflows, protocol parameters, and comparative advantages for advanced cellular and enzymatic assays.

• AKTIP as a Biomarker for Fibrolamellar Carcinoma: A WGCNA an

  2026-05-06

  This study identifies AKTIP as a diagnostic and prognostic biomarker for fibrolamellar carcinoma (FLC) using integrated WGCNA and machine learning methods. The findings offer new directions for FLC diagnosis and potential therapies, with robust experimental and computational validation.

• EZ Cap™ Cre mRNA (m1Ψ): Enhanced Stability for Gene Editing

  2026-05-05

  EZ Cap™ Cre mRNA (m1Ψ) is a stabilized Cre recombinase mRNA featuring N1-Methylpseudouridine and Cap 1 structure, resulting in increased translational efficiency and reduced immunogenicity. This product enables reproducible gene editing workflows with minimized innate immune activation.

• Macrophage TIPE2 Loss Drives ASC Ferroptosis in Obesity

  2026-05-05

  This study uncovers how loss of TIPE2 in visceral adipose tissue macrophages triggers adipose stem cell ferroptosis, leading to impaired fat tissue function and metabolic disease in obesity. Mechanistic insights into mitochondrial fragmentation and iron handling suggest new intervention points for obesity-related disorders.

• TBK1 Inhibition Alleviates Diabetic Neuropathy via Microglia

  2026-05-04

  This study uncovers the pivotal role of TANK-binding kinase 1 (TBK1) in mediating microglia pyroptosis and painful diabetic neuropathy (PDN) in murine diabetes models. By demonstrating that TBK1 inhibition attenuates neuropathic pain through suppression of inflammasome-driven neuroinflammation, the work highlights a novel therapeutic avenue and offers mechanistic clarity for translational diabetes research.

• Pulmonary Pharmacokinetics and Antibacterial Activity of Gam

  2026-05-04

  This study provides the first detailed analysis of Gamithromycin's pharmacokinetics and pulmonary distribution in foals, as well as its in vitro efficacy against key respiratory pathogens, including S. zooepidemicus and R. equi. The findings have important implications for antimicrobial stewardship and rational drug selection in veterinary respiratory disease models.

• ALDOB K87 Lactylation Drives Mitochondrial Fission in PH

  2026-05-03

  This study identifies ALDOB K87 lactylation as a central regulator of mitochondrial fission and metabolic reprogramming in pulmonary hypertension (PH). By mapping the lactate–ALDOB–DRP1 axis in smooth muscle cells, the authors reveal new mechanistic links underpinning pathological vascular remodeling and highlight potential molecular targets for future intervention.

• Superoxide Dismutase (SOD) Activity Assay Kit: Practical Use

  2026-05-02

  The Superoxide Dismutase (SOD) Activity Assay Kit (SKU K2035) enables quantitative measurement of SOD activity in biological fluids, supporting rigorous oxidative stress research where accuracy and reproducibility are critical. It is best used for colorimetric detection of antioxidative enzyme function, but should not be applied to diagnostic or medical workflows. The kit is unsuitable for settings requiring direct clinical interpretation or mechanistic claims beyond its validated colorimetric range.

• In Vitro Pharmacodynamics of Gamithromycin Against MmmSC

  2026-05-02

  This study provides the first detailed in vitro pharmacodynamic analysis of Gamithromycin, ML-1709460, against Mycoplasma mycoides subspecies mycoides Small Colony—the causative agent of contagious bovine pleuropneumonia. The findings clarify serum potentiation effects, comparative efficacy with older macrolides, and inform future research design for bovine respiratory disease therapeutics.

• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S

  2026-05-01

  This study introduces a novel assembloid model integrating patient-matched gastric tumor organoids and stromal cell subpopulations, offering an advanced platform to capture tumor heterogeneity and microenvironmental influences on drug response. The approach enhances preclinical research by enabling detailed investigation of resistance mechanisms and supporting personalization of gastric cancer therapies.

• Starvation Triggers Autophagy–Apoptosis Switch via ER-Ca2+-C

  2026-04-30

  This study elucidates how starvation in Bombyx mori induces a precise transition from autophagy to apoptosis in the fat body through the ER-Ca2+-calpain pathway. The work reveals IP3R-mediated calcium signaling as a key regulatory axis and demonstrates that pharmacological inhibition of this pathway modulates cell fate under nutritional stress.

• Gamithromycin: Precision Use in Veterinary Respiratory Disea

  2026-04-30

  Gamithromycin (ML-1709460) empowers translational and veterinary scientists with optimized, evidence-backed protocols for tackling respiratory pathogens like Haemophilus parasuis and Pasteurella multocida. APExBIO’s formulation delivers reproducibility and data-driven performance in both in vitro and in vivo models.

• ALOX5 Deficiency Drives Ferroptosis Escape in Bladder Cancer

  2026-04-29

  This study identifies ALOX5 deficiency as a key mechanism for ferroptosis resistance in advanced bladder cancer, linking low ALOX5 expression to poor prognosis. By elucidating the transcriptional regulation of ALOX5 and its impact on lipid peroxidation, the research provides a foundation for novel therapeutic strategies targeting ferroptosis pathways.

466 records 20/32 page Previous Next First page 上5页 1617181920 下5页 Last page